Delayed measurement of PTH in patients with CKD: Storage of the primary tube in the dialysis unit, which temperature? Which kind of tube?;Conservation du tube primaire sur le site de dialyse en vue du dosage différé de la PTH : quels tubes ? Quelle température ?

Nephrologie et Therapeutique

Volumn 5, Issue 1, 2009, Pages 34-40

  Parent, Xavier ^a   Alenabi, Farideh ^a   Brignon, Pierre ^a   Souberbielle, Jean Claude ^b  

^a Pasteur Hospital   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

In vitro storage; Parathyroid hormone; Preanalytical conditions; Primary tube

Indexed keywords

APROTININ; CALCIUM; EDETIC ACID; PARATHYROID HORMONE;

ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; HORMONE BLOOD LEVEL; HUMAN; RENAL OSTEODYSTROPHY; RENAL REPLACEMENT THERAPY; ROOM TEMPERATURE; SECONDARY HYPERPARATHYROIDISM;

BLOOD PRESERVATION; CHRONIC DISEASE; HEMODIALYSIS UNITS, HOSPITAL; HUMANS; KIDNEY DISEASES; PARATHYROID HORMONE; RENAL DIALYSIS; TEMPERATURE; TIME FACTORS;

EID: 59149092944     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2008.04.006     Document Type: Article

References (15)

1. K/DOQI. Guidelines for the management of renal osteodystrophy. Am J Kidney Dis 2003;42(suppl. 3):S1-S201.
2. Rottembourg J., Diab R., and Boulechfar H. Comment atteindre et maintenir les recommandations K/DOQI sur le métabolisme phosphocalcique chez les patients dialysés : une stratégie efficace. Nephrol Ther 3 (2007) 33-42
3. Souberbielle J.C., Boutten A., Carlier M.C., Chevenne D., Coumaros G., Lawson-Body E., et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 70 (2006) 345-350
4. Cantor T., yang Z., Caraini N., and Ilamathi E. Lack of comparability of intact parathyroid hormone measurement among commercial assays for end-stage renal disease patients: implication for treatment decision. Clin Chem 52 (2006) 1711-1716
5. Urena-Torres P. The need for reliable serum parathyroid hormone measurement. Kidney Int 70 (2006) 240-243
6. Twoney P.J., Whitlock T., and Pledger D.R. Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice. J Clin Pathol 58 (2005) 1000-1001
7. Holmes D., Levin A., Forer B., and Rosenberg F. Preanalytical influences on DPC Immulite 2000™ intact PTH assays of plasma and serum from dialysis patients. Clin Chem 51 (2005) 915-917
8. Cavalier E., Delanaye P., Carlisi A., Krzesinski J.M., and Chapelle J.P. Stability of intact parathyroid hormone in samples from haemodialysis patients. Kidney Int 72 (2007) 370-372
9. Bacchetta J., Jolivot A., Souberbielle J.C., Charrié A., Guebre F., Chauvet C., et al. Parathormone et maladie rénale chronique. Nephrol Ther 3 (2007) 133-138
10. Anderson N.R., Nicholas J., Holland M.R., and Gama R. Effect of a protease inhibitor on in vitro stability of intact parathyroid hormone. Ann Clin Biochem 40 (2003) 188-190
11. Levin G.E., and Nisbet J.A. Stability of parathyroid hormone-related protein and parathyroid hormone at room temperature. Ann Clin Biochem 31 (1994) 497-500
12. Glendenning P., Musk A., Taranto M., and Vasikaran S. Preanalytical factors in the measurement of intact parathyroid hormone with the DPC Immulite assay. Clin Chem 48 (2002) 566-567
13. Omar H., Chamberlin A., Walker V., and Wood P.J. Immulite 2000™ parathyroid hormone assay; stability of parathyroid hormone in EDTA blood kept at room temperature for 48 h. Ann Clin Biochem 38 (2001) 561-563
14. Glenndenning P., Laffer L., Weber H., Musk A., and Vasikaran S. Parathyroid hormone is more stable in EDTA plasma than in serum. Clin Chem 48 (2002) 766-767
15. Twoney P., Whitlock T., and Pledger D. Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice. J Clin Pathol 58 (2005) 1000-1001